Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...

The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered ...

The newest one is the self-revocation of two seminal CRISPR patents in Europe by the team led by two Nobel Laureates ...

From a universal robot brain to how AI could be better than quantum computing, check out this week's awesome tech stories from around the web.

Canaccord Genuity analyst Whitney Ijem has maintained their bullish stance on NTLA stock, giving a Buy rating today. Whitney Ijem has given ...

In a report released yesterday, Yanan Zhu from Wells Fargo maintained a Buy rating on Intellia Therapeutics (NTLA – Research Report), ...

JMP Securities analyst Silvan Tuerkcan has maintained their neutral stance on NTLA stock, giving a Hold rating on October 25. Silvan ...

The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered ...

The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered ...

The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered ...

The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered ...

The US, which is currently the world’s second-largest greenhouse-gas emitter and has added more climate pollution to the atmosphere than any other nation, is now very unlikely to hit Biden’s 2030 goal ...